Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
This is significant because it may allow an additional reduction in liver fat, potentially helping to reduce liver inflammation and fibrosis, two causes of obesity-related complications
*FOR 18.5% AVERAGE WEIGHT LOSS FOR PROGRAM MEMBERS SOURCE: Reflects data from clients who implemented CVS Weight Management program in 2024, showing average weight loss among engaged members who have been on anti-obesity medication for one year
Important: Lilly Cares does not currently cover Zepbound, but it does cover Mounjaro for diabetes
If TRIUMPH-1 confirms 24% or greater weight loss, retatrutide will clearly surpass both semaglutide (approximately 15% to 17%) and tirzepatide (approximately 20% to 22%) in head-to-head comparisons of their important trial data
US$ 27.02
US$ 23.22
US$ 20.60
